Brief: Dawnrays Pharmaceutical says HY revenue was up 17.4 percent
22/08/2017 05:10
Aug 22 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* Declares an interim dividend of HK$0.03 per share for year
ending 31 December 2017
* HY profit for the period attributable to owners of the
parent RMB149mln, up 13.3 percent
* HY revenue RMB491.1 million, up 17.4 percent
Source text for Eikon: urn:newsml:reuters.com:*:nNRA4cmcqf
Further company coverage: 2348.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO